BRAF inhibitor induced BRAF-CRAF heterodimerization and subsequent activation of ERK signaling in cancer-associated fibroblasts, leading to inactivation of the β-catenin destruction complex.
[Cancer Research]
Sorry, but the selected Zotpress account can't be found.
